Assertio Therapeutics, Inc.
Zvanični podaci iz registra
0pratilaca
2018osnovano
O Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Sjedište251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Osnovano2018
StatusAktivno
Patenti1 patent
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Recenzije
Još nema recenzija. Radili ste s Assertio Therapeutics, Inc.? Budite prvi koji će podijeliti iskustvo.
Pravne informacije
| Pravni naziv | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Pogledajte na GLEIF ↗ |
| Registrovana adresa | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Status | Aktivno |
Izvori: GLEIF · ažurirano 16. oktobar 2026.
Kontakt i linkovi
Lokacija
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Da li je ovo vaša kompanija?
Preuzmite ovu stranicu besplatno da dodate logo, proizvode, fotografije i poslove i da odgovarate na recenzije.
Preuzmite ovu stranicuPridružite se Heelky da se povežete, zapošljavate i rastete
Kreirajte besplatan račun da pišete ljudima, prijavljujete se na poslove i objavljujete misije.
Pridruži se sada — besplatno je